Our research aims to improve health outcomes by studying treatments that promote healthy minds and healthy bodies across your lifespan.
📰Healthy Mind Lab latest:
Washington University researchers test antidepressant for treating long COVID (Links to an external site)
By Russell Kinsaul Published: Mar. 18, 2024 at 5:55 PM CDT Check out the Healthy Mind Lab’s current study on long COVID! Researchers at Washington University are leading the way to find a treatment for a debilitating condition that affects as many as 16 million Americans.
Washington University trial studies antidepressant Fluvoxamine as treatment for Long COVID symptoms (Links to an external site)
ST. LOUIS (KMOV) -A clinical trial at the Washington University School of Medicine is studying the impact of an antidepressant on long COVID symptoms.
Specifically, the study is examining whether Fluvoxamine, a medication used to treat depression and obsessive-compulsive disorder, can relieve problems with “brain fog” and other neurological conditions associated with lingering symptoms.
🔗Healthy Mind Lab Quick Links
📅Want to learn more about Psychiatry? Check out department lectures and presentations:
There are not currently any upcoming events scheduled. Please check back for new events to be added.
In the meantime, if you’d like to explore campus events, please visit Happenings at WashU.
🧠Can I volunteer for a Healthy Mind Lab study?
Healthy Mind Lab is always seeking volunteers for clinical trials. Click below to see if you may be a match!